Severe course of HIV-related Kaposi's sarcoma with cutaneous, visceral and oral manifestations in a late-presenting patient

被引:0
|
作者
Barczak, Szymon [1 ]
Badura, Barbara [1 ]
Lembas, Agnieszka [2 ,3 ]
Mikula, Tomasz [2 ,3 ]
Wiercinska-Drapalo, Alicja [2 ,3 ]
机构
[1] Med Univ Warsaw, Dept Infect & Trop Dis & Hepatol, Students Sci Soc, PL-01201 Warsaw, Poland
[2] Med Univ Warsaw, Dept Infect & Trop Dis & Hepatol, PL-01201 Warsaw, Poland
[3] Warsaws Hosp Infect Dis, PL-01201 Warsaw, Poland
来源
PROSPECTS IN PHARMACEUTICAL SCIENCES | 2024年 / 22卷 / 02期
关键词
HIV; AIDS; Kaposi's sarcoma; HHV-8; chemotherapy;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Kaposi's sarcoma is a soft tissue tumor caused by human herpesvirus 8 (HHV-8). One of its forms is associated with human immunodeficiency virus (HIV) and is characterized by involvement of the skin and internal organs. We present a case of a 42-year-old male diagnosed with acquired immunodeficiency syndrome (AIDS) and disseminated Kaposi's sarcoma with cutaneous, oral and visceral manifestations. During the months of hospitalization the patient suffered from neutropenic fever, gastrointestinal bleedings and required multiple blood transfusions. The patient was started on antiretroviral treatment followed by chemotherapy with paclitaxel. The skin lesions regressed, the patient gained weight and there was an improvement in performance status. This case demonstrates how severe HIV-related Kaposi's sarcoma can be and the effectiveness of antiretroviral treatment combined with chemotherapy in combating the disease. The authors believe that great effort must be made to prevent new HIV infections and all the negative implications that may follow.
引用
收藏
页码:26 / 29
页数:4
相关论文
共 50 条
  • [31] Clinical Significance of Elevated KSHV Viral Load in HIV-Related Kaposi's Sarcoma Patients in South Africa
    Tibenderana, Rebecca Monica
    Blumenthal, Melissa Jayne
    Bukajumbe, Emmanuel
    Schaefer, Georgia
    Mohamed, Zainab
    VIRUSES-BASEL, 2024, 16 (02):
  • [33] Kaposi's sarcoma-like lesions and other nodules as cutaneous involvement in AIDS-related visceral leishmaniasis
    González-Beato, MJ
    Moyano, B
    Sánchez, C
    González-Beato, MT
    Pérez-Molina, JA
    Miralles, P
    Lázaro, P
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (06) : 1316 - 1318
  • [34] When to treat Kaposi's Sarcoma? Paclitaxel survival benefit on classic versus AIDS/HIV-related subtypes.
    Eyzaguirre, Eduardo
    Enriquez, Daniel
    Ku, Gabriel Antonio De la Cruz
    Castro, Victor
    Morante, Zaida
    Valdiviezo, Natalia
    Portillo, Diana
    de Leon, Luis Ernesto Cuellar Ponce
    Mas, Luis
    Gomez, Henry Leonidas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] SAFETY AND EFFICACY OF VEDOLIZUMAB IN A HIV POSITIVE PATIENT WITH KAPOSI'S SARCOMA AND SEVERE ULCERATIVE COLITIS: REPORT OF A CASE
    Pagnini, C.
    Di Paolo, M. C.
    Torcolacci, F.
    De Angelis, G.
    Milano, M.
    Trinca, D.
    Di Sora, F.
    Graziani, M. G.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S128 - S129
  • [36] Kaposi's sarcoma of the intestine in an HIV-negative patient associated with immunosuppressive therapy for severe aplastic anemia
    Abhyankar, SH
    Burns, RG
    Godder, KT
    Pati, AR
    HensleeDowney, PJ
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (01) : 86 - 88
  • [37] Occult lymphadenopathic Kaposi's sarcoma associated with severe pulmonary hypertension:: A clinical hint about the potential role of HHV-8 in HIV-related pulmonary hypertension?
    Gutierrez, Felix
    Masia, Mar
    Padilla, Sergio
    Ramos, Jose M.
    Bernal, Enrique
    Morales, Pilar
    Pozo, Francisco
    Andrada, Encarnacion
    Martin-Hidalgo, Alberto
    JOURNAL OF CLINICAL VIROLOGY, 2006, 37 (02) : 79 - 82
  • [38] PGP 9.5 neuronal marker may differentiate immunohistochemically HIV-related from Mediterranean and immunosuppression-associated Kaposi’s sarcoma
    Vasileia Xyla
    Elias Skopelitis
    Panayiotis D. Ziakas
    Athanasios Kontos
    Eleftherios Ioannidis
    Theodore Kordossis
    Kyriaki Aroni
    Archives of Dermatological Research, 2013, 305 : 917 - 923
  • [39] PGP 9.5 neuronal marker may differentiate immunohistochemically HIV-related from Mediterranean and immunosuppression-associated Kaposi's sarcoma
    Xyla, Vasileia
    Skopelitis, Elias
    Ziakas, Panayiotis D.
    Kontos, Athanasios
    Ioannidis, Eleftherios
    Kordossis, Theodore
    Aroni, Kyriaki
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2013, 305 (10) : 917 - 923
  • [40] SNP screening of central MHC-identified HLA-DMB as a candidate susceptibility gene for HIV-related Kaposi’s sarcoma
    B Aissani
    A K Boehme
    H W Wiener
    S Shrestha
    L P Jacobson
    R A Kaslow
    Genes & Immunity, 2014, 15 : 424 - 429